Jose Lemme-Dumit

Dr. Jose Lemme-Dumit


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 August 2025 in mSphere
Verified
Journal Article
Open access
JLJose Lemme-Dumit
Jose Lemme-Dumit
The intestinal epithelium serves as a critical interface between the external environment and internal tissues, coordinating nutrient absorption, immune defense, and barrier integrity. Discerning the processes that maintain gut homeostasis has been challenging due to the complexity of the intestinal microenvironment and the difficulty in accessing human tissue. The advent of human intestinal organoid technology has transformed the field by providing relevant in vitro models that recapitulate the cellular diversity and function of the gut epithelium. A recent advance involves the integration of immune cells into organoid cultures, enabling the study of epithelial-immune cell interactions in both health and disease. Furthermore, the application of cutting-edge multi-omics approaches, including transcriptomics, proteomics, and metabolomics, has enabled a deeper understanding of intestinal cell signaling, niche factors, and host-microbe dynamics. These innovations have led to breakthroughs in translational research, particularly in the field of precision medicine. This minireview highlights how intestinal organoids derived from human tissue stem cells, coupled with high-resolution omics technologies, are advancing our knowledge of intestinal physiology, host responses, and disease mechanisms. It also describes the emergence of patient-derived organoids as tools to guide personalized therapeutic strategies for conditions such as inflammatory bowel disease and cystic fibrosis. As organoid models continue to evolve, the integration of additional tissue components—such as diverse immune cell lineages, stromal elements, vasculature, neural cells, and microbiota—will more accurately replicate the intricate nature of human physiology and broaden their translational potential.

26 August 2020 in mSphere
Verified
Journal Article
Open access
PDF file
JLJose Lemme-Dumit
Jose Lemme-Dumit
Jose Lemme-Dumit works in the field of mucosal immunology and vaccines. In this mSphere of Influence article, he reflects on how two papers, “Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett’s epithelium” by Sato et al. (T. Sato, D. E. Stange, M. Ferrante, R. G. J. Vries, et al., Gastroenterology 141:1762–1772, 2011, https://doi.org/10.1053/j.gastro.2011.07.050 ) and “T helper cell cytokines modulate intestinal stem cell renewal and differentiation” by Biton et al.

4 September 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
JLJose Lemme-Dumit
Jose Lemme-Dumit
MDMichele Doucet
Michele Doucet
NZNicholas C. Zachos
Nicholas C. Zachos
MPMarcela F. Pasetti
Marcela F. Pasetti
Polymorphonuclear neutrophils (PMN) are recruited to the gastrointestinal mucosa in response to inflammation, injury, and infection. Herein, we report the development and the characterization of an ex vivo tissue co-culture model consisting of human primary intestinal enteroid monolayers and PMN, and a mechanistic interrogation of PMN-epithelial cell interaction and response to Shigella , a primary cause of childhood dysentery. Cellular adaptation and tissue integration, barrier function, PMN phenotypic and functional attributes, and innate immune responses were examined. PMN within the enteroid monolayers acquired a distinct activated/migratory phenotype that was influenced by direct epithelial cell contact as well as by molecular signals. Seeded on the basal side of the intestinal monolayer, PMN intercalated within the epithelial cells and moved paracellularly toward the apical side. Co-cultured PMN also increased basal secretion of IL-8. Shigella added to the apical surface of the monolayers evoked additional PMN phenotypic adaptations, including increased expression of cell surface markers associated with chemotaxis and cell degranulation (CD47, CD66b, and CD88). Apical Shigella infection triggered rapid transmigration of PMN to the luminal side, NET formation as well as bacterial phagocytosis and killing. Shigella infection modulated cytokine production in the co-culture; apical MCP-1, TNF-α, and basolateral IL-8 production were downregulated, while basolateral IL-6 secretion was increased. We demonstrated, for the first time, PMN phenotypic adaptation, mobilization, and coordinated epithelial cell-PMN innate response upon Shigella infection in the human intestinal environment. The enteroid monolayer-PMN co-culture represents a technical innovation for mechanistic interrogation of gastrointestinal physiology, host-microbe interaction, innate immunity, and evaluation of preventive/therapeutic tools. Importance: Studies of mucosal immunity and microbial host cell interaction have traditionally relied on animal models and in vitro tissue culture using immortalized cancer cell lines, which render non-physiological and often unreliable results. Herein we report the development and characterization of an ex vivo enteroid-PMN co-culture consisting of normal human intestinal epithelium and a mechanistic interrogation of PMN and epithelial cell interaction and function in the context of Shigella infection. We demonstrated tissue-driven phenotypic and functional adaptation of PMN and a coordinated epithelial cell and PMN response to Shigella , a primary cause of dysentery in young children in the developing world.

9 October 2026 in npj Vaccines
Verified
Journal Article
Open access
PDF file
GDGirmay Desalegn
Girmay Desalegn
LBLeslie Bautista
Leslie Bautista
LPLucy Pill-Pepe
Lucy Pill-Pepe
CACharlotte Abrahamson
Charlotte Abrahamson
JLJose Lemme-Dumit
Jose Lemme-Dumit
MPMarcela F. Pasetti
Marcela F. Pasetti
Shigella species are a major cause of diarrheal diseases and child mortality worldwide. There is no licensed vaccine to prevent shigellosis, and most candidates target the bacterial O-polysaccharide, which limits their coverage to the vaccine serotype. Conserved Shigella proteins capable of eliciting broadly protective immunity are compelling alternatives for overcoming serotype-restricted responses. We previously reported that VirG is a broadly protective Shigella antigen. Here, we demonstrate the antimicrobial function and cross-protective efficacy of VirG-specific antibodies. Immunization with VirG-derived constructs induced high and durable antigen-specific IgG responses in rabbits, and passive transfer of VirG-specific rabbit antisera conferred significant protection (57.1-75.0%) in mice against lethal S. flexneri 2a and S. sonnei challenge. VirG-specific antibodies recognized native VirG expressed unipolarly by live bacteria and exhibited a range of antimicrobial activities, including bactericidal and opsonophagocytic killing, and inhibition of bacterial adherence and invasion of human colonoids. We demonstrate, for the first time, that Shigella protein-specific antibodies can mediate Shigella killing. In summary, VirG-directed antibodies exhibited robust antimicrobial activity and mediated cross-serotype protection. These findings support VirG as a promising component of next-generation protein-based Shigella vaccines.